ARTICLE

FindCenter AddIcon

Can Psychedelic Experiences Cure Alcohol Addiction?

By Mark Travers — 2019

A new study hints at a novel and promising treatment for alcohol use disorder.

Read on www.psychologytoday.com

FindCenter Post-Image

Yahoo Sports: ‘Why Not Roll the Dice?’ Lamar Odom’s Risky Road Back from Addiction and Depression

It is now more than five years since Odom’s drug abuse prematurely ended his NBA career, destroyed his marriage to Khloe Kardashian and left him comatose for three days in a Las Vegas hospital.

FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon
FindCenter Post-Image

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

FindCenter AddIcon
FindCenter Post-Image

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

FindCenter AddIcon
FindCenter Post-Image

Rapid Antidepressant Effects of the Psychedelic Ayahuasca Linked to Changes in Inflammatory Biomarkers

The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.

FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

FindCenter AddIcon

EXPLORE TOPIC

Addiction Recovery